BIO-Europe Spring® 2017: Key considerations in microbiome partnering

March 29, 2017
The human microbiome is garnering research interest across the globe and industry is responding to the growing possibilities of therapeutic developments in a variety of ways, a key aspect of which is partnerships. The current state of play means emerging companies are often looking for specific expertise or experience in their partners, often influenced by the variety of approaches under different regulatory jurisdictions or financial structures.
Previous Article
Rare Disease Foundation CEO cites collaboration, data sharing as keys to progress
Rare Disease Foundation CEO cites collaboration, data sharing as keys to progress

An interview with Monica Weldon, President of Bridge the Gap – SYNGAP Education and Research Foundation Hou...

Next Article
Biotechs successfully navigate alternative paths to financing
Biotechs successfully navigate alternative paths to financing

Project awards, strategic venture funds and now crowd-funding offer alternatives to traditional venture fun...